27.06.2011 • News

DSM Appoints New Chief Technology Officer

DSM has appointed Marcel Wubbolts, currently vice president R&D DSM Innovation Center, to the position of chief technology officer as of Oct.1, reporting to Rob van Leen, Chief Innovation Officer.

Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent Professor at the ETH in Zürich. He joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, in Jülich, Germany. Thereafter, he was competence manager Biocatalysis & Biotransformations and then became program director at the DSM Innovation Center in Delft, the Netherlands, running the Industrial (White) Biotechnology program

Marcel will succeed Jos Put who will continue to be an advisor to DSM e.g. in the field of material sciences and for several of the DSM Science and Technology awards.

 

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.